Investment Q&A

We still like SIS quite a lot, it is just that it is 'slower' growth. Nothing wrong with that, but the stock has lagged somewhat and we are finding some faster-growing small caps to like 'more'. Debt is still a bit high and there were lots of general tariff worries this year as well which kept us a bit more cautious. But for a healthcare-related stock, we would still consider it one of the better ones, at least in the Canadian space. TCL.A has had a volatile history, but is putting things together. It is a very cheap stock, but there is minimal top-line growth. EPS has improved with operational efficiencies, but this can only go so far. We would warm up to it more if we saw some more sales growth. 2026E sales are expected to be below 2019 levels.